A Plus Biotechnology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2021	FY 2020
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	607.23	604.35	360.97	319.07	305.09	289.31
Short-Term Investments	5	4	30	-	1	1
Cash & Short-Term Investments	612.23	608.35	390.97	319.07	306.09	290.31
Cash Growth	40.00%	55.60%	22.54%	4.24%	5.44%	-
Accounts Receivable	181.05	178.33	184.53	141.67	133.31	133.75
Other Receivables	-	0.18	-	2.11	3.07	1.96
Receivables	181.05	178.5	184.53	143.77	136.38	135.71
Inventory	367.37	354.54	286.94	283.76	300.67	277.13
Prepaid Expenses	38.55	39.37	29.26	17.49	16.06	9.39
Other Current Assets	3.83	6.3	5.15	5.49	2.07	0
Total Current Assets	1,203	1,187	896.85	769.58	761.27	712.54
Property, Plant & Equipment	358.18	243.75	251.91	259.02	233.38	18.16
Long-Term Investments	92.07	87.66	-	-	-	-
Other Intangible Assets	4.53	3.97	6.51	8.24	178.16	176.75
Long-Term Deferred Tax Assets	15.05	13.99	12.66	31.24	9.8	11.6
Other Long-Term Assets	13.61	13.58	9.38	3.26	23.24	11.15
Total Assets	1,686	1,550	1,177	1,071	1,206	930.2
Accounts Payable	47.2	41.06	39.4	28.9	39.81	26.26
Accrued Expenses	-	70.11	72.48	43.69	-	-
Short-Term Debt	-	-	-	-	37.8	31.93
Current Portion of Long-Term Debt	-	4.82	4.72	4.78	-	-
Current Portion of Leases	5.01	8.27	8.07	8.64	9.78	3.76
Current Income Taxes Payable	43.02	32.93	2.95	19.56	7.97	3.83
Current Unearned Revenue	9.36	2.96	0.91	1.49	0.9	2.58
Other Current Liabilities	276.25	37.98	34.77	35.77	107.08	85.27
Total Current Liabilities	380.83	198.13	163.31	142.83	203.35	153.62
Long-Term Debt	157.86	82.38	87.2	93.83	153.98	-
Long-Term Leases	0.5	0.62	6.82	5.79	3.31	2.99
Long-Term Deferred Tax Liabilities	3.25	2.99	0.01	-	0.11	0.38
Other Long-Term Liabilities	0.32	0.32	0.94	0.93	1.16	1
Total Liabilities	542.76	284.45	258.27	243.38	361.91	157.99
Common Stock	345.71	345.71	304.71	304.71	304.71	286.49
Additional Paid-In Capital	-	-	-	360.01	358.55	320.4
Retained Earnings	275.76	347.55	300.05	177.04	179	160.38
Treasury Stock	-43.94	-38.66	-	-14.15	-	-
Comprehensive Income & Other	563.21	608.19	314.29	0.35	1.68	1.1
Total Common Equity	1,141	1,263	919.05	827.94	843.94	768.37
Minority Interest	2.96	2.77	-	-	-	3.84
Shareholders' Equity	1,144	1,266	919.05	827.94	843.94	772.21
Total Liabilities & Equity	1,686	1,550	1,177	1,071	1,206	930.2
Total Debt	163.36	96.1	106.81	113.03	204.87	38.68
Net Cash (Debt)	448.86	512.26	284.16	206.03	101.22	251.64
Net Cash Growth	33.76%	80.27%	37.92%	103.55%	-59.77%	-
Net Cash Per Share	13.27	15.57	9.36	6.81	3.50	8.79
Filing Date Shares Outstanding	34.17	33.7	30.47	30.18	28.64	28.62
Total Common Shares Outstanding	34.17	33.7	30.47	30.18	28.64	28.62
Working Capital	822.2	988.93	733.54	626.75	557.92	558.92
Book Value Per Share	33.38	37.48	30.16	27.43	29.46	26.85
Tangible Book Value	1,136	1,259	912.54	819.7	665.77	591.62
Tangible Book Value Per Share	33.25	37.36	29.95	27.16	23.24	20.67
Land	-	117.34	117.34	117.34	-	-
Buildings	-	116.27	115.92	103.55	-	-
Machinery	-	34.77	35.15	46.84	-	-
Construction In Progress	-	0.1	0.21	13.48	-	-
Leasehold Improvements	-	12.79	5.19	5.62	-	-